Connect your AI

Aurinia Pharmaceuticals AUPH Price / book

Price / book at other companies

Rogers CorporationROG

1.6×+0.6×

Vera TherapeuticsVERA

5.7×+2.9×

ANI PharmaceuticalsANIP

3.1×-0.4×

Ultragenyx PharmaceuticalRARE

316.5×+303×

Agios PharmaceuticalsAGIO

1.8×+0.6×

Kiniksa Pharmaceuticals International, plcKNSA

6.1×+2.6×

Other financials

Income statement

Revenue$77.7M+24.4%

Gross profit$71.2M+32.1%

Operating income$41.4M+89.6%

Net income$34.4M+47.2%

EPS (diluted)$0.25+56.3%

Balance sheet

Cash & equivalents$41.0M-38.3%

Total debt$85.2M-7.9%

Total equity$567.6M+62.1%

Total assets$724.0M+43.4%

Cash flow

Operating cash flow$32.6M+2,405%

Valuation

Market cap$2.3B+78.5%

Enterprise value$2.34B+78.3%

P/E7.7×-24.6×

P/S7.7×+2.5×

Profitability

Gross margin89.7%+1.5pp

Operating margin41.7%+29.4pp

Net margin100%+83.9pp

Returns & leverage

Return on equity65%+53.8pp

Debt / equity0.2×-0.1×

Current ratio5.5×-0.4×

Where this comes from

Calculated from Aurinia Pharmaceuticals’s reported figures.

market cap/total stockholders equity=3.5×

Based on the most recent quarter.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Aurinia Pharmaceuticals's price / book?: Aurinia Pharmaceuticals (AUPH) reported price / book of 3.5× in Q1 2026.
How has Aurinia Pharmaceuticals's price / book changed year-over-year?: Aurinia Pharmaceuticals's price / book increased by 10.1% year-over-year, from 3.2× to 3.5×.
What is the long-term trend for Aurinia Pharmaceuticals's price / book?: Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's price / book has grown at a -5.7% compound annual growth rate (CAGR), from 4.9× to 3.6×.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.